News
-
Study On Teen Mental Health App Shows High Engagement, Positive Impact
A study on BeMe Health, a behavioral health platform for teens, found that users engaged with the platform eight times on average over a month. The study was done in collaboration with Stanford University.
-
Technology is Great. But Does it Really Change Health Outcomes for the Better?
We must advocate for the positive impact that technology can have on healthcare outcomes, while also building solutions to create a more equitable health system. This includes traditional, less tech-reliant methods for those unable to embrace technology.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
At-Home Physical Therapy Leads to Better Recovery in Post-Surgical Patients, Study Shows
Luna — an at-home physical therapy provider — released a new study on the efficacy of its post-surgery rehabilitation program. The study, which was conducted by the startup, showed that the Luna Pathways program did a good job of reducing patients’ pain, increasing care plan adherence, and decreasing avoidable hospital readmissions and emergency department visits.
-
HHS Drops First 10 Drugs for Medicare Drug Price Negotiation
HHS released the first 10 drugs selected for the Medicare Drug Price Negotiation Program. These drugs include Eliquis, Jardiance and Xarelto. Under the program, the federal government will be able to negotiate the price for selected drugs for the first time.
-
BMS Cancer Drug’s New FDA Nod Puts It on Path to Reach Blockbuster Status
Bristol Myers Squibb drug Reblozyl is now approved as a first-line therapy for anemia caused by myelodysplastic syndromes, a group of blood cancers. It’s the third indication for the drug, which analysts project could top $4 billion in peak sales.
-
Consumer / Employer, Devices & Diagnostics, Health Tech
Healthcare Moves: A Monthly Summary of Hires and Layoffs
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
-
Bayer Pushes Ahead With Parkinson’s Cell Therapy on Heels of Positive Phase 1 Data
A Bayer cell therapy for Parkinson’s disease has met primary and secondary goals of its first test in humans, and the pharmaceutical giant is now planning for a larger Phase 2 clinical trial expected to begin enrollment in the first half of next year.
-
MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Andrew Trister, Chief Scientific Officer at Verily
For the August episode, we discuss some recent executive appointments occurring in the healthcare sector, as well as layoffs affecting the industry. We also hear from Andrew Trister, who just became Verily’s chief scientific officer.
-
Regard Teams Up With OpenAI to Develop Chatbot Functionality Built On GPT-4
Regard — a startup selling an AI co-pilot that helps clinicians diagnose medical conditions — announced a new partnership to add to its technology’s capabilities. The company is teaming up with OpenAI to release new chatbot functionalities built on OpenAI’s large language model GPT-4.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Danaher Continues M&A Streak, Buying Life Sciences Firm Abcam for $5.7B
Abcam’s acquisition comes two months after its board announced the exploration of strategic alternatives that could include the sale of the company. Danaher beat out at least 20 companies that were potential buyers of the life sciences tools and antibody development firm.
-
The Journey to Personalized Healthcare
The Walt Disney Company excels in designing exceptional service because they are hyper-focused on listening, tracking, designing, and measuring the experiences of guests visiting their properties. We can apply this approach in pharma by enhancing our patient journey maps and go beyond focusing on the key clinical engagement touch points (e.g., doctor visits, prescription pickups) and enriching our insights with the micro-moments surrounding these obvious events.
-
Are New Primary Care Sites an Opportunity for Nurses?
As nursing remains the most trusted profession and NPs have long been accepted as primary care providers, nurses and NPs are uniquely qualified to guide patients through care interactions and bring the consistency associated with primary care to new places.
-
Hospitals, MedCity Influencers
Navigating the Journey from CMO and Physician to Patient
Even with my “VIP” access to the healthcare system as a physician who practiced in my community, I’m still struggling to coordinate my care as a cancer patient. I believe patients need more from their payers, providers, and digital health collaborators when it comes to care coordination and navigation.
-
New MD Anderson Research Uncovers Drug Combo That Could Eliminate Pancreatic Cancer Tumors
Researchers at the University of Texas MD Anderson Cancer Center published two studies this week on a new approach that could improve treatment for patients with pancreatic cancer. The preclinical studies showed that combining immunotherapy with a KRAS inhibitor can lead to long-lasting tumor elimination.
-
Skin Microbiome and Allergies: Understanding the Role of Microbes in Allergic Skin Conditions
Future research should focus on identifying the interactions between the immune system, microbes, and allergic responses; and exploring potential therapeutic strategies targeting the skin microbiome for allergy management.
-
MedCity Influencers, Health Tech
5 Ways Patient Access Software Solutions Can Transform Mental Health Care
By leveraging sophisticated patient intake forms, robust patient-provider matching algorithms, self-scheduling features, calendar management tools, and telehealth capabilities, healthcare providers can bridge the gap between consumer expectations and the current state of healthcare access.
-
Rapport Therapeutics Snags $150M to Develop Precision Neurology Meds
Rapport Therapeutics, a clinical-stage biotech that was founded last year, raised $150 million in Series B financing, bringing its total funding to date to $250 million. The company’s platform leverages receptor-associated proteins to create neurology drugs that have more focused activity in the brain, going after disease-driving circuits and cell types.
-
85,000 Kaiser Workers Will Soon Vote to Authorize What Could Be the Biggest Healthcare Strike in US History
The Coalition of Kaiser Permanente Unions announced that it will soon begin conducting strike authorization votes among its 85,000 members. The coalition’s chief concern is Kaiser’s dangerous staffing levels, which members say have led to excessively long wait times, patient neglect and mistaken diagnosis. If the coalition authorizes and implements the strike, it will become the largest strike of healthcare workers in the history of the U.S.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
